AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

CUSIP: 037326105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
35,509,556
Total 13F shares
19,415,909
Share change
+708,975
Total reported value
$41,730,123
Price per share
$2.15
Number of holders
45
Value change
-$1,462,207
Number of buys
20
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 037326105?
CUSIP 037326105 identifies ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) as of Q2 2024

As of 30 Jun 2024, AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,415,909 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Octagon Capital Advisors LP, Frazier Life Sciences Management, L.P., TCG Crossover Management, LLC, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and BlackRock Inc.. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.